Hays Advisory’s Pfizer PFE Stock Holding History

Hays Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,538	Closed	-$315K	–	47
2018 Q3	$315K	Buy	7,538 +533	+8%	+$20.5K	0.2%	51
2018 Q2	$241K	Sell	7,005 -577	-8%	-$19.7K	0.13%	59
2018 Q1	$255K	Sell	7,582 -3,188	-30%	-$110K	0.12%	68
2017 Q4	$370K	Buy	10,770 +2,081	+24%	+$71K	0.13%	71
2017 Q3	$294K	Buy	8,689 +748	+9%	+$24K	0.09%	65
2017 Q2	$253K	Buy	7,941 +455	+6%	+$14.3K	0.06%	71
2017 Q1	$243K	Buy	7,486 +777	+12%	+$24.5K	0.06%	72
2016 Q4	$207K	Buy	+6,709	New	+$205K	0.05%	73

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Hays Advisory's PFE Position: Q4 2018 in Review

Hays Advisory sold out of Pfizer (PFE) in Q4 2018, closing a stake of 7,538 shares — an estimated $315K sold.

Hays Advisory first reported a position in PFE in Q4 2016 and held it in 8 quarters. The position peaked at $370K in Q4 2017. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

Hays Advisory reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
Hays Advisory sold 7,538 Pfizer shares in Q4 2018, an estimated $315K.
Hays Advisory first reported a position in Pfizer in Q4 2016 and held it in 8 quarters.
Hays Advisory's Pfizer position peaked at $370K in Q4 2017.
2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Hays Advisory's 13F filing for Q4 2018.